Paroxysmal nocturnal hemoglobinuria (PNH) is an uncommon acquired blood disorder caused by changes in blood-forming stem cells. These changes can make red blood cells vulnerable to destruction by the complement . . .
Living with paroxysmal nocturnal hemoglobinuria (PNH) may require ongoing attention to symptoms and regular communication with healthcare professionals. PNH affects blood cells and can lead to hemolysis, . . .
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder of blood-forming stem cells. It occurs when a mutation affects the production of proteins that normally protect blood cells from destruction . . .
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired blood disorder caused by changes affecting blood cell protection from the complement system. Complement activation can lead to destruction of red blood cells, . . .
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder involving the bone marrow and blood cells. It occurs when a mutation develops in the PIGA gene within . . .
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder caused by a change in blood-forming stem cells. The condition can lead to the destruction of red blood cells, a process . . .
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired blood disorder caused by abnormal hematopoietic stem cells. The condition can lead to complement-mediated destruction of red blood cells, known as hemolysis, . . .
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired blood disorder caused by changes in blood-forming stem cells. These changes can make red blood cells more vulnerable to destruction by the . . .
Paroxysmal nocturnal hemoglobinuria (PNH) is an uncommon acquired disorder of the blood-forming stem cells in the bone marrow. It is not usually inherited or passed from parents to children. PNH . . .
Fabry disease is a rare genetic disorder caused by changes in the GLA gene, which can lead to reduced or absent activity of the enzyme alpha galactosidase A. As a . . .